HAE - Haemonetics Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 3/31/2018 4/1/2017 4/2/2016 3/28/2015
Total Revenue 903,923 886,116 908,832 910,373
Cost of Revenue 490,115 507,622 502,918 475,955
Gross Profit 413,808 378,494 405,914 434,418
Operating Expenses
Research Development 39,228 37,556 44,965 54,187
Selling General and Administrative 302,627 289,243 297,994 337,168
Non Recurring - - - -
Others - - - -
Total Operating Expenses 831,970 834,421 845,877 867,310
Operating Income or Loss 71,953 51,695 62,955 43,063
Income from Continuing Operations
Total Other Income/Expenses Net -12,321 -79,171 -116,371 -11,898
Earnings Before Interest and Taxes 71,953 51,695 62,955 43,063
Interest Expense -7,700 -7,900 -8,500 -8,500
Income Before Tax 59,632 -27,476 -53,416 31,165
Income Tax Expense 14,060 -1,208 2,163 14,268
Minority Interest - - - -
Net Income From Continuing Ops 45,572 -26,268 -55,579 16,897
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 45,572 -26,268 -55,579 16,897
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 45,572 -26,268 -55,579 16,897